Pizotifen Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.5 mg, 1.5 mg
Reference Brands: Mosegor (EU), Sandomigran (EU)
Category:
Neurology
Pizotifen is a serotonin (5-HT2) receptor antagonist with antihistamine properties used for the prevention of migraine and cluster headaches. It helps reduce the frequency and severity of migraine attacks but is not intended for acute treatment. Available mainly as 0.5 mg and 1.5 mg oral tablets, it works by blocking serotonin activity in the brain to prevent blood vessel changes that trigger headaches.
Pizotifen Tablet is available in Tablets
and strengths such as 0.5 mg, 1.5 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pizotifen Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pizotifen Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing